Nuclear Regulation Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer – Nature.com Carmen Lillard Oct 24, 2022 Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer Nature.com